MedPath

IRBESARTAN/HIDROCLOROTIAZIDA RATIO 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

IRBESARTAN/HIDROCLOROTIAZIDA RATIO 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

73348

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jan 25, 2011

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number73348
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

HIDROCLOROTIAZIDAActive
Quantity: 12,5 mg
Name: HIDROCLOROTIAZIDA
IRBESARTANActive
Quantity: 300 mg
Name: IRBESARTAN

ATC CLASSIFICATION (3)

C09D
C09DA
C09DA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.